Estrogen Receptor-positive Metastatic Breast Cancer
📧 Sign up to get email alerts when something new happens for Estrogen Receptor-positive Metastatic Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-09-22Clinical Trial Update: Endocrine Therapy With Abemaciclib or Chemotherapy as Initial Metastatic Treatment in ER+/HER2- Breast Cancer [Phase 3]
Phase 3 trial comparing endocrine therapy with abemaciclib to chemotherapy as initial treatment for ER-positive, HER2-negative metastatic br…
-
CLINICAL_TRIALS trial_result · 2025-07-15Clinical Trial Update: BI 836845 in Estrogen Receptor Positive Metastatic Breast Cancer [Phase 1]
A Phase 1 trial of BI 836845 in estrogen receptor positive metastatic breast cancer has completed, with results posted in 2025.
-
CLINICAL_TRIALS trial_result · 2024-06-06Clinical Trial Update: Study of AZD2014 and Palbociclib in Patients With Estrogen Receptor Positive (ER+) Metastatic Breast Cancer [Phase 1]
Phase 1 study evaluating AZD2014 in combination with palbociclib for estrogen receptor-positive metastatic breast cancer has completed.